| 1 |
Perez-Tejada J, Labaka A, Vegas O, Larraioz A, Pescador A, Arregi A. Anxiety and depression after breast cancer: The predictive role of monoamine levels. Eur J Oncol Nurs 2021;52:101953. [PMID: 33813184 DOI: 10.1016/j.ejon.2021.101953] [Reference Citation Analysis]
|
| 2 |
Twigg J, Anderson J, Humphris G, Nixon I, Rogers S, Kanatas A. Best practice in reducing the suicide risk in head and neck cancer patients: a structured review. British Journal of Oral and Maxillofacial Surgery 2020;58:e6-e15. [DOI: 10.1016/j.bjoms.2020.06.035] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 3 |
Geoffroy PA, Tebeka S, Blanco C, Dubertret C, Le Strat Y. Shorter and longer durations of sleep are associated with an increased twelve-month prevalence of psychiatric and substance use disorders: Findings from a nationally representative survey of US adults (NESARC-III). Journal of Psychiatric Research 2020;124:34-41. [DOI: 10.1016/j.jpsychires.2020.02.018] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 4 |
Huillard O, Le Strat Y, Dubertret C, Goldwasser F, Mallet J. RE: Associations Between Breast Cancer Survivorship and Adverse Mental Health Outcomes: A Systematic Review. J Natl Cancer Inst 2019;111:335-6. [PMID: 30629204 DOI: 10.1093/jnci/djz003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 5 |
Moryl N, Malhotra VT. A Case for Palliative Care and Addiction Specialists Collaboration and Joint Research. JAMA Netw Open 2021;4:e2143436. [PMID: 34962563 DOI: 10.1001/jamanetworkopen.2021.43436] [Reference Citation Analysis]
|
| 6 |
Vehling S, Mehnert-Theuerkauf A, Philipp R, Härter M, Kraywinkel K, Kuhnert R, Koch U. Prevalence of mental disorders in patients with cancer compared to matched controls - secondary analysis of two nationally representative surveys. Acta Oncol 2022;61:7-13. [PMID: 34731069 DOI: 10.1080/0284186X.2021.1992008] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 7 |
Carreira H, Williams R, Müller M, Harewood R, Stanway S, Bhaskaran K. Response to Hulliard, Le Strat, Dubertre, et al. J Natl Cancer Inst 2019;111:337. [PMID: 30629200 DOI: 10.1093/jnci/djz004] [Reference Citation Analysis]
|
| 8 |
Lu W, Pikhart H, Peasey A, Kubinova R, Pitman A, Bobak M. Risk of depressive symptoms before and after the first hospitalisation for cancer: Evidence from a 16-year cohort study in the Czech Republic. J Affect Disord 2020;276:76-83. [PMID: 32697719 DOI: 10.1016/j.jad.2020.06.070] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 9 |
Fitzgerald Jones K, Khodyakov D, Arnold R, Bulls H, Dao E, Kapo J, Meier D, Paice J, Liebschutz J, Ritchie C, Merlin J. Consensus-Based Guidance on Opioid Management in Individuals With Advanced Cancer-Related Pain and Opioid Misuse or Use Disorder. JAMA Oncol 2022. [PMID: 35771550 DOI: 10.1001/jamaoncol.2022.2191] [Reference Citation Analysis]
|
| 10 |
Riedl D, Schüßler G. Factors associated with and risk factors for depression in cancer patients - A systematic literature review. Transl Oncol 2022;16:101328. [PMID: 34990907 DOI: 10.1016/j.tranon.2021.101328] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
